When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
JNJ - Tracon Pharma up 17% premarket on rights to cancer candidate TRC253
Johnson & Johnson
TRACON Pharmaceuticals (NASDAQ:TCON) announces that it has retained global rights to TRC253 after Johnson & Johnson (NYSE:JNJ) unit Janssen Pharmaceutica N.V. decided not to exercise its option for worldwide rights following a review of Phase 2 data in certain prostate cancer patients.
More news on: TRACON Pharmaceuticals, Inc., Johnson & Johnson, Healthcare stocks news, Stocks on the move,